Clinical trial
Positioning of Esketamine Treatment in the Real-world Management of Depression
NCT06103760 is registered in ClinicalTrials.gov with Royal North Shore Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Positioning of Esketamine Treatment in the Real-world Management of Depression
- Lead sponsor
- Royal North Shore Hospital
- Phase
- Phase 4
- Overall status
- Recruiting
- Start date
- October 31, 2023
- Completion date
- August 15, 2028
- Enrollment
- 162 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.